Cardiac Output Response to Vasopressine in major abdominal surgery patients under mechanical ventilation. A clinical pharmacodynamics study

Cardiac Output Response to Vasopressine in major abdominal surgery patients under mechanical ventilation. A clinical pharmacodynamics study - CORVaso

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2021-000841-42-FR

Enrollment

Registered

2021-03-09

Start date

2021-04-28

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: ARGIPRESSINE Pharmaceutical Form: Solution for solution for infusion INN or Proposed INN: ARGIPRESSIN CAS Number: 113-79-1 Concentration unit: IU international unit(s) Concentration type:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 8 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 7

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Main Objective: -;Secondary Objective: -;Primary end point(s): -;Timepoint(s) of evaluation of this end point: -	—

Secondary

Measure	Time frame
Secondary end point(s): -;Timepoint(s) of evaluation of this end point: -	—

Countries

France

Contacts

Public ContactInvestigator coordinator

CHU CLERMONT-FERRAND

tgodet@chu-clermontferrand.fr0033473750501

Outcome results